Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Polymyalgia Rheumatica Treatment Market: By Diagnostic Method: Blood Tests, Imaging Tests; By Drug Class: Corticosteroids, Others; By Route of Administration; By End Use; Regional Analysis; Historical Market and Forecast (2016-2026); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Polymyalgia Rheumatica Treatment Market Outlook

The global polymyalgia rheumatica treatment market attained a value of about USD 177 million in 2020. The market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 4.8% to reach nearly USD 233 million by 2026.

 

Extensive Use of Medications in the Treatment of Polymyalgia Rheumatica Boosting the Market Growth

Polymyalgia is usually treated with medications such as corticosteroids to ease symptoms and uneasiness. Steroids are one of the most common drugs for polymyalgia rheumatica treatment. It can ease pain and stiffness in a few days. However, the use of the drug requires extensive monitoring as it can lead to serious side effects, such as loss of bone density, cataracts, and high blood pressure. This leads to routine diagnostic tests to monitor the effect and treatment of the disease, hence augmenting the industry growth. Moreover, the growing demand for immune suppressing medications such as methotrexate in the early course of treatment is significantly contributing to the market growth.

 

Global Polymyalgia Rheumatica Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

In addition, the development of drugs that can treat various rheumatological diseases, such as polymyalgia rheumatica and rheumatoid arthritis, is propelling the market growth. This is expected to surge its demand among people with several health-related issues, to significantly contribute to the market growth. Moreover, the introduction of clinical programs by leading companies to evaluate the safety and efficiency of novel drugs is invigorating the growth of the polymyalgia rheumatica treatment industry.

 

Polymyalgia Rheumatica Treatment: Industry Definition and Segmentation

Polymyalgia rheumatica treatment is the treatment of the inflammatory disorder that causes stiffness, muscle pain, and inflammation in the hips and shoulders. It is usually prevalent among the geriatric population, especially women. It is treated by using corticosteroids, methotrexate, and vitamin D supplements.

The major diagnostic methods of polymyalgia rheumatica treatment are:

  • Blood Tests
  • Imaging Tests

The market can be broadly categorised on the basis of its drug class into:

  • Corticosteroids
  • Disease-Modifying Anti-Rheumatic Drugs
  • Non-steroidal Anti-Inflammatory Drugs
  • Others

Based on route of administration, the market is divided into:

  • Oral
  • Parenteral

By end use, the market is classified into:

  • Hospitals
  • Homecare
  • Speciality Clinics
  • Others

The EMR report looks into the regional markets of polymyalgia rheumatica treatment like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Rising Deployment of Advanced Diagnostic Technology to Augment the Polymyalgia Rheumatica Treatment Industry

Increasing research on polymyalgia rheumatica to study its association with musculoskeletal symptoms is expected to augment the market growth. The deployment of advanced diagnostic technologies to analyse subacromial and subdeltoid bursitis of shoulders, hip synovitis, and iliopectineal bursitis, to develop their effective treatment is projected to propel the industry growth. Moreover, technological advancements in imaging tests such as magnetic resonance imaging (MRI) are minimising its scorer bias to diagnose the disease effectively. As MRI can detect asymptomatic cases of polymyalgia rheumatica, it is surging the demand for its treatment, which is consequently accelerating the market growth of polymyalgia rheumatica treatment.

As physical therapy does not result in side effects, its popularity is significantly growing. This is increasing the demand for physiotherapy in the treatment of polymyalgia rheumatica, which is propelling the industry growth. Physiotherapies are customised based on the severity of diseases to provide a personalised treatment of the disease, due to which it is increasingly being adopted. Physiotherapy can aid in enhancing cardiovascular levels, reducing stiffness, improving mobility, and increasing muscle strength to allow patients to live at norm and ease, therefore significantly contributing to the market growth. Moreover, the rising availability of specific physiotherapy programs at hospitals and speciality clinics is surging their accessibility, which is providing further impetus to the growth of the polymyalgia rheumatica treatment industry.

 

Key Industry Players in the Global Polymyalgia Rheumatica Treatment Market

The report presents a detailed analysis of the following key players in the global polymyalgia rheumatica treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Sanofi SA
  • Apotex Corporation
  • GlaxoSmithKline plc
  • AbbVie Inc.
  • Horizon Therapeutics plc
  • Others

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2016-2020
Forecast Period 2021-2026
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Diagnostic Method, Drug Class, Route of Administration, End Use, Region
Breakup by Diagnostic Method Blood Tests, Imaging Tests
Breakup by Drug Class Corticosteroids, Disease-Modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-Inflammatory Drugs, Others
Breakup by Route of Administration Oral, Parenteral
Breakup by End Use Hospitals, Homecare, Speciality Clinics, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Sanofi SA, Apotex Corporation, GlaxoSmithKline plc, AbbVie Inc., Horizon Therapeutics plc, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Polymyalgia Rheumatica Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Polymyalgia Rheumatica Treatment Historical Market (2016-2020) 
    8.3    Global Polymyalgia Rheumatica Treatment Market Forecast (2021-2026)
    8.4    Global Polymyalgia Rheumatica Treatment Market by Diagnostic Method
        8.4.1    Blood Tests
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2016-2020)
            8.4.1.3    Forecast Trend (2021-2026)
        8.4.2    Imaging Tests
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2016-2020)
            8.4.2.3    Forecast Trend (2021-2026)
    8.5    Global Polymyalgia Rheumatica Treatment Market by Drug Class
        8.5.1    Corticosteroids
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2016-2020)
            8.5.1.3    Forecast Trend (2021-2026)
        8.5.2    Disease-Modifying Anti-Rheumatic Drugs
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2016-2020)
            8.5.2.3    Forecast Trend (2021-2026)
        8.5.3    Nonsteroidal Anti-Inflammatory Drugs
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2016-2020)
            8.5.3.3    Forecast Trend (2021-2026)
        8.5.4    Others
    8.6    Global Polymyalgia Rheumatica Treatment Market by Route of Administration
        8.6.1    Oral
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2016-2020)
            8.6.1.3    Forecast Trend (2021-2026)
        8.6.2    Parenteral
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2016-2020)
            8.6.2.3    Forecast Trend (2021-2026)
    8.7    Global Polymyalgia Rheumatica Treatment Market by End Use
        8.7.1    Hospitals
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2016-2020)
            8.7.1.3    Forecast Trend (2021-2026)
        8.7.2    Homecare
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2016-2020)
            8.7.2.3    Forecast Trend (2021-2026)
        8.7.3    Speciality Clinics
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2016-2020)
            8.7.3.3    Forecast Trend (2021-2026)
        8.7.4    Others
    8.8    Global Polymyalgia Rheumatica Treatment Market by Region
        8.8.1    Market Share
            8.8.1.1    North America
            8.8.1.2    Europe
            8.8.1.3    Asia Pacific
            8.8.1.4    Latin America
            8.8.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2016-2020)
        9.1.2    Forecast Trend (2021-2026)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2016-2020)
        9.2.2    Forecast Trend (2021-2026)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2016-2020)
        9.3.2    Forecast Trend (2021-2026)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2016-2020)
        9.4.2    Forecast Trend (2021-2026)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2016-2020)
        9.5.2    Forecast Trend (2021-2026)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Competitive Landscape
    11.1    Market Structure
    11.2    Company Profiles
        11.2.1    Sanofi SA
            11.2.1.1    Company Overview
            11.2.1.2    Product Portfolio
            11.2.1.3    Demographic Reach and Achievements
            11.2.1.4    Certifications
        11.2.2    Apotex Corporation
            11.2.2.1    Company Overview
            11.2.2.2    Product Portfolio
            11.2.2.3    Demographic Reach and Achievements
            11.2.2.4    Certifications
        11.2.3    GlaxoSmithKline plc
            11.2.3.1    Company Overview
            11.2.3.2    Product Portfolio
            11.2.3.3    Demographic Reach and Achievements
            11.2.3.4    Certifications
        11.2.4    AbbVie Inc.
            11.2.4.1    Company Overview
            11.2.4.2    Product Portfolio
            11.2.4.3    Demographic Reach and Achievements
            11.2.4.4    Certifications
        11.2.5    Horizon Therapeutics plc
            11.2.5.1    Company Overview
            11.2.5.2    Product Portfolio
            11.2.5.3    Demographic Reach and Achievements
            11.2.5.4    Certifications
        11.2.6    Others
12    Industry Events and Developments

 

List of Figures and Tables

1.    Global Polymyalgia Rheumatica Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Polymyalgia Rheumatica Treatment Historical Market: Breakup by Diagnostic Method (USD Million), 2016-2020
3.    Global Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Diagnostic Method (USD Million), 2021-2026
4.    Global Polymyalgia Rheumatica Treatment Historical Market: Breakup by Drug Class (USD Million), 2016-2020
5.    Global Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Drug Class (USD Million), 2021-2026
6.    Global Polymyalgia Rheumatica Treatment Historical Market: Breakup by Route of Administration (USD Million), 2016-2020
7.    Global Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Route of Administration (USD Million), 2021-2026
8.    Global Polymyalgia Rheumatica Treatment Historical Market: Breakup by End Use (USD Million), 2016-2020
9.    Global Polymyalgia Rheumatica Treatment Market Forecast: Breakup by End Use (USD Million), 2021-2026
10.    Global Polymyalgia Rheumatica Treatment Historical Market: Breakup by Region (USD Million), 2016-2020
11.    Global Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Region (USD Million), 2021-2026
12.    North America Polymyalgia Rheumatica Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
13.    North America Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
14.    Europe Polymyalgia Rheumatica Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
15.    Europe Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
16.    Asia Pacific Polymyalgia Rheumatica Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
17.    Asia Pacific Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
18.    Latin America Polymyalgia Rheumatica Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
19.    Latin America Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
20.    Middle East and Africa Polymyalgia Rheumatica Treatment Historical Market: Breakup by Country (USD Million), 2016-2020
21.    Middle East and Africa Polymyalgia Rheumatica Treatment Market Forecast: Breakup by Country (USD Million), 2021-2026
22.    Global Polymyalgia Rheumatica Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global polymyalgia rheumatica treatment market attained a value of nearly USD 177 million.

The market is projected to grow at a CAGR of 4.8% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 233 million by 2026.

The industry is being aided by the growing use of steroids in the treatment of polymyalgia treatment and the introduction of clinical programs for the development of novel treatments.

The market is expected to be driven by the rising demand for physical therapy, increasing research on polymyalgia rheumatica treatment, and the advancements in diagnostic technologies.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major diagnostic methods of polymyalgia rheumatica treatment in the industry are blood tests and imaging tests.

The significant drug class in the market are corticosteroids, disease-modifying anti-rheumatic drugs, and non-steroidal anti-inflammatory drugs, among others.

The different routes of administration of polymyalgia rheumatica treatment are oral and parenteral.

The various end uses of polymyalgia rheumatica treatment are hospitals, homecare, and speciality clinics, among others.

The major players in the industry are Sanofi SA, Apotex Corporation, GlaxoSmithKline plc, AbbVie Inc., and Horizon Therapeutics plc, among others.

Analyst Review

The global polymyalgia rheumatica treatment market attained a value of nearly USD 177 million in 2020, driven by the introduction of various clinical programs. Aided by the growing demand for physical therapy, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 4.8%. The market is projected to reach about USD 233 million by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By diagnostic method, the market is bifurcated into blood tests and imaging tests. Based on its drug class, the polymyalgia rheumatica treatment industry can be segmented into corticosteroids, disease-modifying anti-rheumatic drugs, and non-steroidal anti-inflammatory drugs, among others. On the basis of routes of administration, the industry is divided into oral and parenteral. By end uses, the market is classified into hospitals, homecare, and speciality clinics, among others. The major regional markets for polymyalgia rheumatica treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Sanofi SA, Apotex Corporation, GlaxoSmithKline plc, AbbVie Inc., and Horizon Therapeutics plc, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER